Aditya Kohli
Corporate Officer/Principal bei HILLEVAX, INC.
Vermögen: 13 Mio $ am 31.03.2024
Profil
Aditya Kohli is the founder of Passage Bio, Inc. (founded in 2017), Scout Bio, Inc. (founded in 2019), and Phathom Pharmaceuticals, Inc. (founded in 2019).
At Scout Bio, Inc., he holds the title of Director starting in 2019.
Dr. Kohli is also the founder of Recida Therapeutics, Inc. Dr. Kohli's current job(s) include being a Venture Partner at Frazier Management LLC since 2016, a Vice President at Frazier Life Sciences IX LP since 2016, and the Chief Business Officer at HilleVax, Inc. since 2021.
Dr. Kohli's former job includes being an Engagement Manager at McKinsey & Co., Inc. from 2014 to 2016.
Dr. Kohli's education history includes undergraduate and graduate degrees from the Massachusetts Institute of Technology and a doctorate degree from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HILLEVAX, INC
1,59% | 05.04.2024 | 789 776 ( 1,59% ) | 13 Mio $ | 31.03.2024 |
Aktive Positionen von Aditya Kohli
| Unternehmen | Position | Beginn |
|---|---|---|
| HILLEVAX, INC. | Corporate Officer/Principal | 19.02.2024 |
Scout Bio, Inc.
 Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Founder | 01.04.2019 |
Frazier Life Sciences IX LP
 Frazier Life Sciences IX LP Investment ManagersFinance Frazier Life Sciences IX LP invests in companies located in the US. The fund focuses on companies operating in the fields of pharmaceuticals, healthcare services, medical services and distribution. It provides financing for seed, early and later stage capital requirements. | Corporate Officer/Principal | 01.09.2016 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Private Equity Analyst | 01.09.2016 |
Ehemalige bekannte Positionen von Aditya Kohli
| Unternehmen | Position | Ende |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Founder | 01.12.2021 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.09.2016 |
Recida Therapeutics, Inc.
 Recida Therapeutics, Inc. BiotechnologyHealth Technology Recida Therapeutics, Inc. engages in the development of novel therapeutics. The company was founded by Yigong Ge, Aditya Kohli, and David A. Socks in 2016 and is headquartered in Menlo Park, CA. | Founder | - |
| PASSAGE BIO, INC. | Founder | - |
Ausbildung von Aditya Kohli
| Massachusetts Institute of Technology | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PASSAGE BIO, INC. | Health Technology |
| PHATHOM PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Frazier Life Sciences IX LP
Frazier Life Sciences IX LP Investment ManagersFinance Frazier Life Sciences IX LP invests in companies located in the US. The fund focuses on companies operating in the fields of pharmaceuticals, healthcare services, medical services and distribution. It provides financing for seed, early and later stage capital requirements. | Finance |
Scout Bio, Inc.
Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
Recida Therapeutics, Inc.
Recida Therapeutics, Inc. BiotechnologyHealth Technology Recida Therapeutics, Inc. engages in the development of novel therapeutics. The company was founded by Yigong Ge, Aditya Kohli, and David A. Socks in 2016 and is headquartered in Menlo Park, CA. | Health Technology |
| HilleVax, Inc. |
